Watanabe K et al. |
Donor bone marrow cell facilitates induction of tolerance to kidney allografts in dogs treated with fractionated lymphoid irradiation and FK 506. |
1991 |
Transplant. Proc. |
pmid:1703706
|
Mueller AR et al. |
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease. |
1994 |
Transplant. Proc. |
pmid:7527951
|
Kobayashi N et al. |
Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation. |
1991 |
Transplant. Proc. |
pmid:1703707
|
Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Tze WJ et al. |
Immunohistochemical studies of pig islet xenograft in rats immunosuppressed with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513470
|
Masutani K et al. |
Protocol biopsy findings in living donor kidney transplant patients treated with once-daily or twice-daily tacrolimus formulation. |
2014 |
Transplant. Proc. |
pmid:24655972
|
Cherala G et al. |
Tacrolimus pharmacokinetics in Hispanic children after kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:22172831
|
Stringa P et al. |
Pretreatment Combination Reduces Remote Organ Damage Secondary to Intestinal Reperfusion Injury in Mice: Follow-up Study. |
|
Transplant. Proc. |
pmid:26915870
|
Kang Y et al. |
Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689889
|
Herrero JC et al. |
Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications. |
2002 |
Transplant. Proc. |
pmid:11959201
|
Facundo C et al. |
Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:11959203
|
Wachtman GS et al. |
Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. |
2011 |
Transplant. Proc. |
pmid:22099837
|
Samuel D et al. |
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636563
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Vilalta R et al. |
Delayed graft function is reduced with antithymocyte globulin induction in pediatric kidney transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715923
|
Moochhala SM et al. |
Inhibition of drug metabolism in rat and human liver microsomes by FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721277
|
Lauro A et al. |
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908252
|
Pan F et al. |
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. |
1996 |
Transplant. Proc. |
pmid:8623373
|
Nakao A et al. |
Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat. |
2000 |
Transplant. Proc. |
pmid:11120044
|
Burkhalter F et al. |
High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study. |
2012 |
Transplant. Proc. |
pmid:23195006
|
Bora F et al. |
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients. |
2012 |
Transplant. Proc. |
pmid:23195020
|
Undre NA et al. |
Pharmacokinetics of tacrolimus: clinically relevant aspects. |
1999 |
Transplant. Proc. |
pmid:10576037
|
Charco R et al. |
Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation. |
2005 |
Transplant. Proc. |
pmid:16386588
|
Crespo-Leiro MG |
Calcineurin inhibitors in heart transplantation. |
2005 |
Transplant. Proc. |
pmid:16386614
|
Morimoto T et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the dog. |
1990 |
Transplant. Proc. |
pmid:1691550
|
Yasunami Y et al. |
Characterization of the immunosuppressive activity of FK 506 in rat islet allografts. |
1990 |
Transplant. Proc. |
pmid:1691557
|
Nishikawa S et al. |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. |
2009 |
Transplant. Proc. |
pmid:19917404
|
Walker S et al. |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. |
1998 |
Transplant. Proc. |
pmid:9636618
|
Sathyan S et al. |
A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab. |
2009 |
Transplant. Proc. |
pmid:19917422
|
Pérez-Flores I et al. |
Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus. |
2010 |
Transplant. Proc. |
pmid:20970565
|
Marzoa-Rivas R et al. |
Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase. |
2010 |
Transplant. Proc. |
pmid:20970591
|
Marzorati S et al. |
Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249555
|
Lodewijk L et al. |
Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249561
|
de Paulis A et al. |
Antiinflammatory effect of FK 506 on human basophils. |
1991 |
Transplant. Proc. |
pmid:1721309
|
Nardo B et al. |
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7518112
|
Jain A et al. |
Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. |
2005 |
Transplant. Proc. |
pmid:15848671
|
Pan F et al. |
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. |
1994 |
Transplant. Proc. |
pmid:7518113
|
Bäckman L et al. |
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533361
|
Söderdahl G et al. |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man. |
1995 |
Transplant. Proc. |
pmid:7533362
|
Wynn C et al. |
High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication. |
2002 |
Transplant. Proc. |
pmid:12176408
|
Marcén R et al. |
Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study. |
2006 |
Transplant. Proc. |
pmid:17097957
|
Mortensen DM et al. |
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. |
2006 |
Transplant. Proc. |
pmid:17098028
|
Reding R et al. |
Compassionate use of FK 506 in pediatric liver transplantation: a pilot study. |
1991 |
Transplant. Proc. |
pmid:1721341
|
Lee KK et al. |
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. |
1990 |
Transplant. Proc. |
pmid:1702239
|
Uemoto S et al. |
Experience with FK 506 in living related donor liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721342
|
Borrows R et al. |
Steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil: three-year results. |
2005 |
Transplant. Proc. |
pmid:15919468
|
Loucaidou M et al. |
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe. |
2005 |
Transplant. Proc. |
pmid:15919469
|
Bismuth H |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533415
|
Rabkin JM et al. |
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176483
|
Langrehr JM et al. |
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV. |
2002 |
Transplant. Proc. |
pmid:12176487
|
Lyne JC et al. |
Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123015
|
Meçule A et al. |
Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen. |
2011 |
Transplant. Proc. |
pmid:21620042
|
Zucker K et al. |
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123027
|
Sugitani A et al. |
Intestinal neurons in acute and chronic rejection after small bowel transplantation in dogs. |
1996 |
Transplant. Proc. |
pmid:8907941
|
Ronchetti F et al. |
Mucosal hyaluronic acid quantification in small bowel transplantation in pigs. |
1996 |
Transplant. Proc. |
pmid:8907950
|
Choi JY and Kwon OJ |
Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants? |
2013 |
Transplant. Proc. |
pmid:24156999
|
Hebert MF et al. |
Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721373
|
Eiras G et al. |
Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells. |
1991 |
Transplant. Proc. |
pmid:1703357
|
Takahara S et al. |
Monitoring of FK 506 blood levels in kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7520623
|
Sun CK et al. |
Intensive care after orthotopic liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7520627
|
Takayama K et al. |
Hepatocyte growth factor and vascular endothelial growth factor expression in pig-to-primate xenotransplanted hearts. |
2000 |
Transplant. Proc. |
pmid:10936314
|
Izbicki G et al. |
Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. |
2002 |
Transplant. Proc. |
pmid:12493439
|
Ushigome H et al. |
Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center. |
2002 |
Transplant. Proc. |
pmid:12176533
|
Weir M |
Impact of immunosuppressive regimes on posttransplant diabetes mellitus. |
2001 |
Transplant. Proc. |
pmid:11498201
|
Kaibori M et al. |
Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083347
|
Kim JD et al. |
Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. |
2016 |
Transplant. Proc. |
pmid:27320573
|
el-Ghoroury M et al. |
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123461
|
Mueller AR et al. |
Long-term follow-up in hepatitis C patients with respect to immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8962255
|
Abu-Elmagd KM et al. |
Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721404
|
Yamada K et al. |
FK 506-induced juxtaglomerular apparatus hyperplasia and tubular damage in rat kidney--morphologic and biologic analysis. |
1992 |
Transplant. Proc. |
pmid:1379756
|
Fukuse T et al. |
Optimal dose of FK 506 in canine lung allotransplantation. |
1992 |
Transplant. Proc. |
pmid:1379757
|
Tanaka M et al. |
Reduction of immunosuppressive agents after living related donor liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8769268
|
Ishibashi M et al. |
Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay. |
1989 |
Transplant. Proc. |
pmid:2469228
|
Alessiani M et al. |
Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus. |
2000 |
Transplant. Proc. |
pmid:10995915
|
Madariaga JR et al. |
The long-term efficacy of multivisceral transplantation. |
2000 |
Transplant. Proc. |
pmid:10995918
|
Molinaro M et al. |
Pharmacokinetics of tacrolimus during the early phase after heart transplantation. |
2001 |
Transplant. Proc. |
pmid:11377570
|
van Riemsdijk IC et al. |
Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta system. |
2002 |
Transplant. Proc. |
pmid:12176606
|
McCarter JF et al. |
FK 506 protects brain tissue in animal models of stroke. |
2001 |
Transplant. Proc. |
pmid:11377571
|
Baran DA et al. |
Predictors of early renal insufficiency in cardiac transplant recipients initiated on tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176609
|
Dick TB et al. |
Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients. |
2011 |
Transplant. Proc. |
pmid:21911143
|
Abouljoud M et al. |
Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267175
|
Kauffman HM et al. |
Drug regimens affect cadaveric kidney graft survival. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267176
|
Ettenger RB |
New immunosuppressive agents in pediatric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9723350
|
Collin C et al. |
Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. |
2010 |
Transplant. Proc. |
pmid:21168693
|
Kuroki H et al. |
Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721436
|
Ito T et al. |
Bone marrow cell- and FK 506-induced donor-specific unresponsiveness in rat heart allografts. |
1991 |
Transplant. Proc. |
pmid:1721437
|
Todo S et al. |
Orthotopic liver transplantation in dogs receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445079
|
Grabczewska Z et al. |
Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index. |
2013 |
Transplant. Proc. |
pmid:23726621
|
Lim SM et al. |
Heterotopic heart transplantation in the rat receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445080
|
Dikow R et al. |
Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. |
2004 |
Transplant. Proc. |
pmid:15251373
|
Renner FC et al. |
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. |
2013 |
Transplant. Proc. |
pmid:23726630
|
Groetzner J et al. |
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267373
|
Chávez R et al. |
Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin. |
1999 |
Transplant. Proc. |
pmid:10500655
|
Ginevri F et al. |
Expression of collagen by renal fibroblasts treated with FK 506 in vitro. |
1998 |
Transplant. Proc. |
pmid:9636387
|
Hutchinson IV et al. |
Differences in the mode of action of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636388
|
Fu Q et al. |
Risk Factors for Acute Rejection After Deceased Donor Kidney Transplantation in China. |
2018 |
Transplant. Proc. |
pmid:30316380
|
Suarez Benjumea A et al. |
Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. |
2016 |
Transplant. Proc. |
pmid:27932111
|
Halim MA et al. |
De novo Crohn's disease in a renal transplant recipient. |
2007 |
Transplant. Proc. |
pmid:17524953
|
Rodriguez Cubillo B et al. |
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. |
2016 |
Transplant. Proc. |
pmid:27932117
|
Carl S et al. |
Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept. |
1998 |
Transplant. Proc. |
pmid:9636502
|